EUDA Health (EUDA) to Release Earnings on Wednesday

EUDA Health (NASDAQ:EUDAGet Free Report) is anticipated to release its results before the market opens on Wednesday, February 25th. Analysts expect EUDA Health to post earnings of $0.02 per share and revenue of $6.3630 million for the quarter.

EUDA Health Stock Up 1.5%

EUDA stock opened at $0.90 on Monday. EUDA Health has a twelve month low of $0.71 and a twelve month high of $4.30. The company has a market cap of $34.12 million, a P/E ratio of -7.52 and a beta of -0.14. The business’s fifty day moving average is $1.74 and its 200-day moving average is $2.16.

Institutional Trading of EUDA Health

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC bought a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDAFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health as of its most recent filing with the Securities and Exchange Commission. 4.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of EUDA Health in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Check Out Our Latest Research Report on EUDA

About EUDA Health

(Get Free Report)

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.

See Also

Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.